Stocks and Investing Stocks and Investing
Wed, March 2, 2022
[ 12:00 AM ] - WOPRAI
Timothy Chiodo Maintained (SOFI) at Hold with Decreased Target to $16 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Kyle Peterson Maintained (CDLX) at Strong Buy with Decreased Target to $85 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Anthony Crowdell Maintained (CMS) at Strong Buy with Decreased Target to $70 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Simon Flannery Maintained (TMUS) at Buy and Held Target at $150 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Joshua Wilson Maintained (TILE) at Buy with Decreased Target to $17 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Michael Swartz Downgraded (THO) to Hold on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Steven Shemesh Maintained (TGT) at Buy with Increased Target to $294 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Krisztina Katai Maintained (TGT) at Strong Buy with Increased Target to $353 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Christopher Horvers Maintained (TGT) at Buy with Increased Target to $290 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Kelly Bania Maintained (TGT) at Buy with Increased Target to $295 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Greg Konrad Maintained (TDY) at Strong Buy and Held Target at $530 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Vikram Purohit Maintained (TBPH) at Sell with Increased Target to $11 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Kristine Liwag Maintained (TXT) at Buy with Increased Target to $90 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Arvind Ramnani Maintained (TWKS) at Buy with Decreased Target to $28 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Kevin Mcveigh Maintained (TWKS) at Hold with Decreased Target to $25 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Daniel Perlin Maintained (TWKS) at Buy with Decreased Target to $31 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Ashwin Shirvaikar Maintained (TWKS) at Strong Buy with Decreased Target to $30 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Michael Morris Initiated (TTD) at Strong Buy and Held Target at $108 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Matthew Boss Maintained (URBN) at Hold with Increased Target to $32 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Ian Macpherson Maintained (WHD) at Hold with Increased Target to $55 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
David Begleiter Maintained (WLKP) at Strong Buy with Increased Target to $31 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Craig Irwin Upgraded (WKHS) to Strong Buy and Held Target at $140 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Michael Shlisky Maintained (WKHS) at Hold with Decreased Target to $100 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Manav Patnaik Upgraded (WSC) to Buy and Increased Target to $50 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Mason Carrico Maintained (VCYT) at Buy with Decreased Target to $44 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
C. Gregory Peters Maintained (VRSK) at Buy with Decreased Target to $220 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Scott Devitt Downgraded (VRM) to Hold and Decreased Target to $320 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Ashish Sabadra Maintained (ADT) at Hold with Decreased Target to $9 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
Daniel Imbro Upgraded (ACVA) to Buy and Increased Target to $19 on, Mar 2nd, 2022
[ 12:00 AM ] - WOPRAI
David Lebowitz Maintained (ARQT) at Buy with Increased Target to $37 on, Mar 2nd, 2022

David Lebowitz Maintained (ARQT) at Buy with Increased Target to $37 on, Mar 2nd, 2022


Published on 2024-10-27 19:54:57 - WOPRAI, David Lebowitz
  Print publication without navigation


David Lebowitz of Morgan Stanley, Maintained "Arcutis Biotherapeutics, Inc." (ARQT) at Buy with Increased Target from $35 to $37 on, Mar 2nd, 2022.

David, nor any peers, have made any analyst calls on ARQT in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30
Contributing Sources